Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University of Erlangen-Nürnberg Medical School clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Germany and Israel registers with University of Erlangen-Nürnberg Medical School as lead sponsor. Synced 17 Nov 2026
48Current trials
39Recruiting now
2Drugs in these trials
2Trial registers
At a glance

University of Erlangen-Nürnberg Medical School is the lead sponsor of 48 current clinical trials in our Germany and Israel registers. 39 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Cisplatin and Dapagliflozin Tab. The most-studied condition is Cancer.

ClinicalTrials.gov trials by status

  • Recruiting3981%
  • Not yet open24%
  • Active, closed715%

Trials by phase

  • Not applicable2144%
  • Observational2042%
  • Phase 248%
  • Phase 2/324%
  • Phase 412%
01

Clinical trials sponsored by University of Erlangen-Nürnberg Medical School

48 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy
NCT07313878 · ClinicalTrials.gov ↗ · Acute Lymphoblastic Leukaemias (ALL), Long Term Follow-Up
Not applicable Recruiting 2025-11 Germany
Transfer Effects of Stationary Bicycle Perturbation Training on Older Adults' Cycling Skills
NCT06453473 · ClinicalTrials.gov ↗ · Older Adults, Exercise Training, Bicycling
Not applicable Recruiting 2025-03 Germany, Israel
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
NCT07131956 · ClinicalTrials.gov ↗ · Prostate Cancer (Diagnosis), Prostate Cancer Patients Who Have Brachytherapy Seed Implant, Prostate Cancer Patients Treated by Radiotherapy
Observational Recruiting 2025-12 Germany
Immune Biomarker Study for Salivary Gland Carcinoma
NCT06047236 · ClinicalTrials.gov ↗ · Salivary Gland Tumor, Benign Salivary Gland Tumor
Observational Recruiting 2024-01 Germany
Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family Caregivers
NCT07721701 · ClinicalTrials.gov ↗ · Mild Cognitive Disorder, Alzheimer Disease, Vascular Dementia
Observational Recruiting 2020-08 Germany
MPN Childhood Registry
NCT07410247 · ClinicalTrials.gov ↗ · Childhood Myeloproliferative Neoplasms
Observational Recruiting 2023-01 Germany
Non-invasive Evaluation of Graft Condition in Adult Patients With Kidney Transplant Using Ultrasound Localization Microscopy and Multispectral Optoacoustic Tomography
NCT06472947 · ClinicalTrials.gov ↗ · Kidney Transplant, Kidney Biopsy
Observational Recruiting 2024-06 Germany
Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases
NCT04067167 · ClinicalTrials.gov ↗ · Cancer, Cancer Cachexia, Inflammation
Not applicable Recruiting 2019-05 Germany
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
NCT03975322 · ClinicalTrials.gov ↗ · Oral Leukoplakia, Oral Leukoplakia of Tongue, Oral Leukoplakia of Gingiva
Observational Recruiting 2019-12 Germany
Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and/or Proteinuria Using Ultrasound Localization Microscopy
NCT07469059 · ClinicalTrials.gov ↗ · Nephritis
Observational Recruiting 2025-09 Germany
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
NCT03249519 · ClinicalTrials.gov ↗ · Cervical Cancer
Drug: Cisplatin
Not applicable Recruiting 2017-08 Germany
Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy
NCT07021820 · ClinicalTrials.gov ↗ · Centronuclear Myopathy
Observational Recruiting 2025-05 Germany
Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoarthritis
NCT05887284 · ClinicalTrials.gov ↗ · Arthrosis, Osteoarthritis
Not applicable Recruiting 2023-07 Germany
Smart and Fit for Kidney Transplantation
NCT06040281 · ClinicalTrials.gov ↗ · Chronic Kidney Disease Requiring Chronic Dialysis
Not applicable Recruiting 2023-09 Germany
De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
NCT06030440 · ClinicalTrials.gov ↗ · Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx
Phase 2/3 Recruiting 2024-01 Germany
OCTA in Cardiovascular Disease and Healthy Controls
NCT07359664 · ClinicalTrials.gov ↗ · Patients With Cardiovascular Disease, Healthy Participants
Not applicable Recruiting 2025-12 Germany
Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours
NCT03238378 · ClinicalTrials.gov ↗ · Locally Recurrent Head and Neck Cancer
Not applicable Recruiting 2017-03 Germany
Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
NCT06947668 · ClinicalTrials.gov ↗ · Squamous Cell Carcinoma of Oropharynx, Squamous Cell Carcinoma of the Hypopharynx, Larynx Squamous Cell Carcinoma
Observational Recruiting 2025-05 Germany
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
NCT05397262 · ClinicalTrials.gov ↗ · Bladder Cancer
Not applicable Recruiting 2017-03 Germany
The Erlanger Stroke Registry (ESPro) is the Only Ongoing Prospective Population-based Stroke Registry in Germany, Started in 1994. ESPro Includes All Hospitalized and Non-hospitalized Patients With Stroke in the Community of Erlangen (120.000 Inhabitants), With a Long-life Follow-up.
NCT07771335 · ClinicalTrials.gov ↗ · Intracerebral Haemorrhage (ICH), Cerebral Infarction, Cerebral Infarction Due to Thrombosis of Cerebral Arteries
Observational Recruiting 1994-04 Germany
Fontan-Sprechstunde
NCT05563376 · ClinicalTrials.gov ↗ · Univentricular Heart
Not applicable Recruiting 2020-09 Germany
Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine
NCT07661940 · ClinicalTrials.gov ↗ · AKI - Acute Kidney Injury
Phase 2 Recruiting 2026-09 Germany
Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carcinomas of the Head and Neck Region
NCT06464198 · ClinicalTrials.gov ↗ · Locally Advanced Salivary Gland Carcinoma
Observational Recruiting 2024-06 Germany
Quantification of Brain and Kidney Perfusion Before, During, and After Hypothermia Treatment in Neonates With Perinatal Asphyxia Using Contrast-enhanced Ultrasound
NCT06611254 · ClinicalTrials.gov ↗ · Perinatal Asphyxia, Hypothermia Treatment, Gestational Age Min. 36SSW
Observational Recruiting 2024-06 Germany
More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL and Other Cancers - a Monocentric Late Effects Study (MaximALL)
NCT07705178 · ClinicalTrials.gov ↗ · Acute Lymphatic Leukemia, Lymphoma
Not applicable Recruiting 2026-07 Germany
Non-invasive Preoperative Tissue Evaluation in Head and Neck Tumor Patients Using Multispectral Optoacoustic Tomography (MSOT)
NCT06716892 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Healthy
Observational Recruiting 2024-11 Germany
Predicting Cancer Risk With Digital and Molecular Markers
NCT06962670 · ClinicalTrials.gov ↗ · Breast Cancer, Lung Cancer, Colorectal Cancer
Not applicable Recruiting 2024-09 Germany
Effects of Dietary Supplementation With omega3-fatty Acids (Fish Oil) and Progressive Resistance Training on Skeletal Muscle Status in Gynaecological, Gastrointestinal and Urological Cancer Patients
NCT07643558 · ClinicalTrials.gov ↗ · Cancer Cachexia, Omega 3, Resistance Training
Not applicable Recruiting 2026-01 Germany
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
NCT06367257 · ClinicalTrials.gov ↗ · Squamous Cell Carcinoma of Head and Neck
Not applicable Recruiting 2024-02 Germany
Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial
NCT02391051 · ClinicalTrials.gov ↗ · Prostate Cancer
Phase 2 Recruiting 2014-10 Germany
Ultrasound Localization Microscopy in Patient With Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
NCT06921733 · ClinicalTrials.gov ↗ · Congenital Anomalies of Kidney and Urinary Tract, Lower Urinary Tract Obstruction, Congenital, Ureteropelvic Junction Obstruction
Observational Recruiting 2025-05 Germany
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
NCT04892849 · ClinicalTrials.gov ↗ · HNSCC, NSCLC, Esophageal Cancer
Observational Recruiting 2021-04 Germany
Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and Receiving LDRT
NCT02653079 · ClinicalTrials.gov ↗ · Chronic Inflammatory Disorder
Observational Recruiting 2016-06 Germany
Effects of Intermittent Fasting and Exercise on Inflammation, Metabolism, and the Microbiome in Metabolic Syndrome
NCT06885255 · ClinicalTrials.gov ↗ · Metabolic Syndrome, Obesity and Obesity-related Medical Conditions
Not applicable Recruiting 2023-06 Germany
Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis
NCT06556407 · ClinicalTrials.gov ↗ · Treatment Resistant Hypertension, Chronic Hemodialysis
Not applicable Recruiting 2024-03 Germany
Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
NCT06560801 · ClinicalTrials.gov ↗ · Chronic Kidney Diseases
Phase 4 Recruiting 2023-07 Germany
Prospective Evaluation of Univentricular Hearts
NCT05620030 · ClinicalTrials.gov ↗ · Univentricular Heart
Not applicable Recruiting 2021-05 Germany
Immune Biomarker Study for Head and Neck Cancer
NCT05375266 · ClinicalTrials.gov ↗ · Head and Neck Cancer, Oral Cavity Cancer, Oropharyngeal Cancer
Observational Recruiting 2022-05 Germany
Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Assess the Response of LDRT in Heel Spur With Plantar Fasciitis
NCT06969820 · ClinicalTrials.gov ↗ · Calcaneal Spur
Observational Recruiting 2026-06 Germany
Whole-Body Electromyostimulation and Speed Climbing
NCT07926932 · ClinicalTrials.gov ↗ · Athletic Performance
Not applicable Not yet open 2026-11 Germany
HIIT-based Exercise Intervention for Improvement of Immunomodulatory, Cardiopulmonary, and Psychosocial Parameters During Maintenance Therapy of Paediatric Acute Lymphoblastic Leukaemia (HEALL)
NCT07936786 · ClinicalTrials.gov ↗ · Leukemia, HIIT, Sport
Not applicable Not yet open 2027-01 Germany
Proteinuria and Renal Perfusion in Renal Transplant Recipients
NCT06051812 · ClinicalTrials.gov ↗ · Pre-kidney Transplant, Living Donor Kidney Transplantation, Renal Perfusion
Observational Active, closed 2021-09 Germany
Accuracy of Prediction Equations to Calculate Maximum Strength
NCT06718699 · ClinicalTrials.gov ↗ · Healthy Aging
Observational Active, closed 2024-12 Germany
Enhancement of Neurocognitive Functions by Hippocampal Sparing Radiotherapy
NCT01849484 · ClinicalTrials.gov ↗ · Radiation of Neurocranial Region
Phase 2 Active, closed 2013-03 Germany
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
NCT07352540 · ClinicalTrials.gov ↗ · Osteoarthritis, Knee
Phase 2/3 Active, closed 2026-01 Germany
WB-EMS Effects on Cardiometabolic Risk Factors
NCT07406191 · ClinicalTrials.gov ↗ · Hypertension, Metabolic Syndrome, Hypercholesterolemia
Not applicable Active, closed 2026-02 Germany
Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost
NCT01849510 · ClinicalTrials.gov ↗ · Spinal Metastases
Phase 2 Active, closed 2013-03 Germany
Renal Denervation in ADPKD- RDN-ADPKD Study
NCT05460169 · ClinicalTrials.gov ↗ · Uncontrolled Hypertension, Autosomal Dominant Polycystic Kidney Disease, Renal Denervation
Not applicable Active, closed 2022-06 Germany

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in University of Erlangen-Nürnberg Medical School trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in University of Erlangen-Nürnberg Medical School trials

101 conditions
Cancer2Cancer Cachexia2Metabolic Syndrome2Squamous Cell Carcinoma of the Hypopharynx2Univentricular Heart2Head and Neck Cancer2Acute Lymphoblastic Leukaemias (ALL)1Long Term Follow-Up1Pre-kidney Transplant1Living Donor Kidney Transplantation1Renal Perfusion1End Stage Renal Disease1Healthy Aging1Radiation of Neurocranial Region1Prostate Cancer (Diagnosis)1Prostate Cancer Patients Who Have Brachytherapy Seed Implant1Prostate Cancer Patients Treated by Radiotherapy1Prostate Cancer Recurrent1Salivary Gland Tumor1Benign Salivary Gland Tumor1Mild Cognitive Disorder1Alzheimer Disease1Vascular Dementia1Dementia in Other Diseases Classified Elsewhere1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Germany4839
Clinical trials in Israel11

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Cancer

SponsorTrials
University Health Network, Toronto15
Hospices Civils de Lyon10
British Columbia Cancer Agency5
Ottawa Hospital Research Institute4
University of Calgary4
GRAIL4
Institut du Cancer de Montpellier - Val d'Aurelle4
Institut Curie4
University Hospital, Brest4
Centre hospitalier de l'Université de Montréal (CHUM)4

Sponsors with the most current trials registered for this condition.

06

Questions about University of Erlangen-Nürnberg Medical School trials

How many clinical trials does University of Erlangen-Nürnberg Medical School sponsor?

University of Erlangen-Nürnberg Medical School is the lead sponsor of 48 current trials on ClinicalTrials.gov in our Germany and Israel registers, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are University of Erlangen-Nürnberg Medical School trials recruiting?

Yes. 39 of its 48 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University of Erlangen-Nürnberg Medical School testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Cisplatin (1) and Dapagliflozin Tab (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.